We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · February 18, 2021

Payments for Noninsulin Glucose-Lowering Drugs

Diabetes Care


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Care
Trends in Total and Out-of-Pocket Payments for Noninsulin Glucose-Lowering Drugs Among U.S. Adults With Large-Employer Private Health Insurance From 2005 to 2018
Diabetes Care 2021 Feb 09;[EPub Ahead of Print], H Shao, M Laxy, SR Benoit, YJ Cheng, EW Gregg, P Zhang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading